Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ADIL Adial Pharmaceuticals Inc

1,3301

0,0201 (1,53%)

Zuletzt aktualisiert: 19:51:17

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Adial Pharmaceuticals Charts.

Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Adial Pharmaceuticals Charts.

News Adial Pharmaceuticals Inc

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th
Mittwoch 29 Mai 2024 (6 Tage vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Mittwoch 15 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Montag 22 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Mittwoch 10 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Dienstag 2 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Samstag 2 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Dienstag 13 Februar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 25 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 25 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Adial Pharmaceuticals Inc News-Artikel

Invesco QQQ Trust Series 1

Health Care Select Sector

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen